Concepedia

Takemichi Fukasawa

TF

30

Publications

1.2K

Citations

19

H-Index

1976

Active since

Affiliations

The University of Tokyo(Current)

University of Tokyo Hospital

National Center for Global Health and Medicine

National Institute of Advanced Industrial Science and Technology

Kyowa Kirin (Japan)

Takemichi Fukasawa is an author at The University of Tokyo specializing in medicine, immunology, and scleroderma.

ORCID

Top concepts

Publications per year

1976–2024

30

Publications

30

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

Satoshi Ebata, Ayumi Yoshizaki, Koji Oba et al. · The Lancet Rheumatology · 2021 · 238 citations

, , +6

Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis

Ai Kuzumi, Ayumi Yoshizaki, Kazuki Matsuda et al. · Nature Communications · 2021 · 77 citations · Full text

Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis

Takemichi Fukasawa, Ayumi Yoshizaki, Satoshi Ebata et al. · Arthritis & Rheumatology · 2017 · 75 citations · Full text

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial

Satoshi Ebata, Ayumi Yoshizaki, Koji Oba et al. · The Lancet Rheumatology · 2022 · 70 citations

, , +7

Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease

Satoshi Ebata, Ayumi Yoshizaki, Takemichi Fukasawa et al. · The Journal of Dermatology · 2019 · 63 citations

Rows per page

1–5 of 30